What is Northland Capmk’s Estimate for Arteris Q1 Earnings?

Arteris, Inc. (NASDAQ:AIP) – Stock analysts at Northland Capmk issued their Q1 2026 earnings per share (EPS) estimates for Arteris in a note issued to investors on Wednesday, February 19th. Northland Capmk analyst G. Richard forecasts that the company will post earnings of ($0.14) per share for the quarter. The consensus estimate for Arteris’ current full-year earnings is ($0.71) per share. Northland Capmk also issued estimates for Arteris’ Q2 2026 earnings at ($0.11) EPS, Q3 2026 earnings at ($0.10) EPS and Q4 2026 earnings at ($0.07) EPS.

Arteris (NASDAQ:AIP) last posted its quarterly earnings results on Tuesday, February 18th. The company reported ($0.19) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.08). The company had revenue of $15.49 million during the quarter, compared to analyst estimates of $15.34 million. Arteris had a negative net margin of 58.27% and a negative return on equity of 828.71%.

Several other research analysts also recently commented on AIP. Rosenblatt Securities reissued a “buy” rating and set a $15.00 target price on shares of Arteris in a research note on Tuesday. Northland Securities boosted their target price on Arteris from $14.00 to $16.00 and gave the stock an “outperform” rating in a research note on Wednesday.

Arteris Stock Down 5.8 %

AIP stock opened at $9.28 on Friday. The company has a quick ratio of 1.16, a current ratio of 1.17 and a debt-to-equity ratio of 0.30. The company has a market cap of $380.02 million, a PE ratio of -10.67 and a beta of 1.18. Arteris has a 52 week low of $5.76 and a 52 week high of $12.64. The business has a 50-day simple moving average of $10.53 and a 200 day simple moving average of $8.72.

Institutional Trading of Arteris

Several hedge funds and other institutional investors have recently made changes to their positions in AIP. US Bancorp DE bought a new stake in shares of Arteris during the third quarter worth about $34,000. Dynamic Technology Lab Private Ltd bought a new stake in shares of Arteris during the third quarter worth about $226,000. MetLife Investment Management LLC boosted its holdings in Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after acquiring an additional 9,551 shares during the last quarter. Jacobs Levy Equity Management Inc. boosted its holdings in Arteris by 36.3% in the third quarter. Jacobs Levy Equity Management Inc. now owns 253,211 shares of the company’s stock valued at $1,955,000 after acquiring an additional 67,414 shares during the last quarter. Finally, Needham Investment Management LLC boosted its holdings in Arteris by 14.7% in the third quarter. Needham Investment Management LLC now owns 2,735,000 shares of the company’s stock valued at $21,114,000 after acquiring an additional 350,000 shares during the last quarter. 64.36% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Isabelle F. Geday sold 15,550 shares of the business’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $9.03, for a total transaction of $140,416.50. Following the sale, the director now directly owns 121,213 shares in the company, valued at approximately $1,094,553.39. The trade was a 11.37 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Nicholas B. Hawkins sold 5,000 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $8.56, for a total value of $42,800.00. Following the sale, the chief financial officer now owns 190,414 shares in the company, valued at approximately $1,629,943.84. This trade represents a 2.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 367,157 shares of company stock valued at $3,828,388. 33.70% of the stock is currently owned by corporate insiders.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.